Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coinfection with Strongyloides and SARS-CoV-2: A Systematic Review.
Rosca EC, Heneghan C, Spencer EA, Plüddemann A, Maltoni S, Gandini S, Onakpoya IJ, Evans D, Conly JM, Jefferson T. Rosca EC, et al. Among authors: spencer ea. Trop Med Infect Dis. 2023 Apr 25;8(5):248. doi: 10.3390/tropicalmed8050248. Trop Med Infect Dis. 2023. PMID: 37235296 Free PMC article. Review.
Viral cultures, cycle threshold values and viral load estimation for assessing SARS-CoV-2 infectiousness in haematopoietic stem cell and solid organ transplant patients: a systematic review.
Jefferson T, Spencer EA, Conly JM, Rosca EC, Maltoni S, Brassey J, Onakpoya IJ, Evans DH, Heneghan CJ, Plüddemann A. Jefferson T, et al. Among authors: spencer ea. J Hosp Infect. 2023 Feb;132:62-72. doi: 10.1016/j.jhin.2022.11.018. Epub 2022 Dec 5. J Hosp Infect. 2023. PMID: 36473552 Free PMC article.
Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease.
Vermeire S, Dubinsky MC, Rabizadeh S, Panetta JC, Spencer EA, Dreesen E, D'Haens G, Dervieux T, Laharie D. Vermeire S, et al. Among authors: spencer ea. Clin Res Hepatol Gastroenterol. 2024 May 13;48(6):102374. doi: 10.1016/j.clinre.2024.102374. Online ahead of print. Clin Res Hepatol Gastroenterol. 2024. PMID: 38750934
Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
Spencer EA, Dubinsky MC, Kamm MA, Chaparro M, Gionchetti P, Rizzello F, Gisbert JP, Wright EK, Schulberg JD, Hamilton AL, McGovern DPB, Dervieux T. Spencer EA, et al. Front Immunol. 2024 Jan 23;15:1342477. doi: 10.3389/fimmu.2024.1342477. eCollection 2024. Front Immunol. 2024. PMID: 38476237 Free PMC article.
Corrigendum: Poor prognostic factors of pharmacokinetic origin predict outcomes in inflammatory bowel disease patients treated with anti-tumor necrosis factor-α.
Spencer EA, Dubinsky MC, Kamm MA, Chaparro M, Gionchetti P, Rizzello F, Gisbert JP, Wright EK, Schulberg JD, Hamilton AL, McGovern DPB, Dervieux T. Spencer EA, et al. Front Immunol. 2024 Feb 27;15:1383704. doi: 10.3389/fimmu.2024.1383704. eCollection 2024. Front Immunol. 2024. PMID: 38476224 Free PMC article.
117 results